SCHEMBL4509101

SCHEMBL4509101

COC1=CC(=O)O[C@@]1(C)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48
HCAR2 Q8TDS4 5/20 0.45
HCAR3 P49019 2/20 0.45
CYP1A2 P05177 2/20 0.45
POLB P06746 1/20 0.44
MAPT P10636 4/20 0.42
LMNA P02545 1/20 0.42
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SIRT1 Q96EB6 3/20 0.39
MMP2 P08253 1/20 0.34
MMP9 P14780 1/20 0.34
DHODH Q02127 1/20 0.34
CYP3A4 P08684 1/20 0.33
KDM1A O60341 1/20 0.33
MAOA P21397 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4496221 1.00 KDM4E (0.48) KDM4EHPGDHCAR2HCAR3CYP1A2
SCHEMBL4502815 1.00 KDM4E (0.48) KDM4EHPGDHCAR2HCAR3CYP1A2
SCHEMBL4500703 0.75 HCAR2 (0.51) KDM4EHPGDHCAR2HCAR3CYP1A2
SCHEMBL4503649 0.75 HCAR2 (0.51) KDM4EHPGDHCAR2HCAR3CYP1A2
SCHEMBL4500250 0.75 HCAR2 (0.51) KDM4EHPGDHCAR2HCAR3CYP1A2
SCHEMBL27729251 0.75 HCAR2 (0.47) KDM4EHPGDHCAR2HCAR3CYP1A2
SCHEMBL4663240 0.72 CYP3A4 (0.43) KDM4EHPGDHCAR2HCAR3POLB
SCHEMBL28548234 0.71 HCAR2 (0.53) HCAR2HCAR3CYP1A2SIRT1MMP2
SCHEMBL8125015 0.66 HCAR2 (0.62) HCAR2HCAR3CYP1A2
SCHEMBL11293467 0.65 HCAR2 (0.72) HCAR2HCAR3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612099-B2 Vinylogous acid derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-03 US disclosed
EP-1957483-A1 NOVEL VINYLOGOUS ACIDS DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-08-20 EP disclosed
WO-2007063010-A1 NOVEL VINYLOGOUS ACIDS DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-06-07 WO disclosed
US-20070129421-A1 Vinylogous acid derivatives HOFFMANN-LA ROCHE INC. 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129421-A1 Vinylogous acid derivatives CMA1, TPSG1, TPSAB1 KDM4E 1758/4885HPGD 233/4885HCAR2 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.